- Home
- VRNT vs HROW Comparison
VRNT vs HROW Comparison
Compare VRNT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- HROW
- Stock Information
- Founded
- VRNT 1994
- HROW 1998
- Country
- VRNT United States
- HROW United States
- Employees
- VRNT N/A
- HROW N/A
- Industry
- VRNT EDP Services
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- VRNT Technology
- HROW Health Care
- Exchange
- VRNT Nasdaq
- HROW Nasdaq
- Market Cap
- VRNT 1.5B
- HROW 1.3B
- IPO Year
- VRNT N/A
- HROW N/A
- Fundamental
- Price
- VRNT $24.72
- HROW $36.10
- Analyst Decision
- VRNT Buy
- HROW Strong Buy
- Analyst Count
- VRNT 7
- HROW 4
- Target Price
- VRNT $35.67
- HROW $55.00
- AVG Volume (30 Days)
- VRNT 721.4K
- HROW 307.5K
- Earning Date
- VRNT 12-04-2024
- HROW 11-13-2024
- Dividend Yield
- VRNT N/A
- HROW N/A
- EPS Growth
- VRNT 2980.37
- HROW N/A
- EPS
- VRNT 0.95
- HROW N/A
- Revenue
- VRNT $920,749,000.00
- HROW $169,138,000.00
- Revenue This Year
- VRNT $4.50
- HROW $50.31
- Revenue Next Year
- VRNT $4.45
- HROW $47.75
- P/E Ratio
- VRNT $25.60
- HROW N/A
- Revenue Growth
- VRNT 4.45
- HROW 48.15
- 52 Week Low
- VRNT $21.28
- HROW $9.13
- 52 Week High
- VRNT $38.17
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- VRNT 39.98
- HROW 49.93
- Support Level
- VRNT $24.19
- HROW $33.04
- Resistance Level
- VRNT $26.64
- HROW $36.13
- Average True Range (ATR)
- VRNT 0.95
- HROW 1.87
- MACD
- VRNT -0.28
- HROW 0.30
- Stochastic Oscillator
- VRNT 13.84
- HROW 72.98
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.